Project Manager

Poseida Therapeutics, Inc. is seeking an outstanding Project Manager to join our team. The Project Manager is a key member of the team and will partner with internal team leaders and external partners to develop and implement research and clinical projects to support our therapeutic programs. The ideal candidate will identify, implement, and organize programs across cross-functional teams. The Project Manager will collaborate with teams to develop program strategy and timelines through completion.  

Primarily, the role will:

  • Establish and maintain project schedules to enable accurate development and execution of team strategy, objectives, and timelines
  • Potential to directly manage some projects depending on background and expertise
  • Identify key deliverables from each function and inter-dependencies
  • Ensure successful coordination of work assigned to members of the project teams, including Regulatory, Clinical Operations, Process Development, and Research
  • Identify and help manage risks, conflicts and barriers to program success
  • Develop timelines, budget and resource requirements for all projects and prospective projects under consideration
  • Oversee and prepare and track project team budgets including resources and costs collaborating with Finance and other departments
  • Identify project issues or resource gaps and facilitate resolutions
  • Monitor and communicate project progress and variance through timeline management and deliverable summaries, provided to management as required
  • Ensure project team activities and decisions are clearly communicated, documented and archived, act as a primary contact for project team related information
  • Facilitate project team meetings, cross functional communication and decision making
  • Assist in devising, analyzing and interpreting complex experiments to support projects
  • Represent the company with vendors, potential partners and CROs, including contributing to contract development
  • Responsible for leading high impact across functional initiatives

Qualifications
Required Experience and Skills:

  • Must have both standard project management experience (organization, Gantt charts, budgeting etc.) and in-depth experience in basic/clinical science
  • Must have degree in life sciences, microbiology, biology or other related discipline
  • Must have a minimum of 5 years of multi-disciplinary experience within pharmaceutical, life sciences, biotechnology industry with at least 2 years’ project management experience
  • Gene or cell therapy experience preferred
  • Assay development experience preferred
  • Demonstrated scientific achievements such as publications and documented project successes
  • Project Management Professional (PMP) certification preferred
  • Strong proficiency with project management practices, tools and methodology including Gantt Charts, MS Project and Power Point.
  • Excellent knowledge of overall drug development process with knowledge of key functions to include research, pre-clinical, toxicology, regulatory, PD, PK, clinical research and manufacturing
  • Experience managing Industry and IND-enabling projects
  • Ability to read, analyze, and interpret common scientific and technical journals, financial reports and legal documents
  • Complex Problem solving abilities with focus on accomplishing company goals and objectives in a dynamic business environment
  • Outstanding written and oral communication and negotiation skills are essential
  • Strong leader with focus and drive to succeed—confidence, passion, results oriented and high energy
  • Ability to present thoughts clearly and concisely to a wide variety of stakeholders including senior management, directors, and corporate partners

Poseida Therapeutics is translating best-in-class gene engineering technologies into lifesaving cell therapies. The company is developing CAR T-cell immunotherapies for multiple myeloma, prostate and other cancer types, as well as gene therapies for orphan diseases. P-BCMA-101 is Poseida’s lead CAR-T therapy currently in Phase 1 clinical development for the treatment of multiple myeloma. Poseida has assembled a suite of industry-leading gene engineering technologies, including the piggyBac™ DNA Modification System, TAL-CLOVER™ and Cas-CLOVER™ site-specific nucleases, and Footprint-Free™ Gene Editing (FFGE). For more information, visit www.poseida.com.